STRAP

Research STRAP on Bullrun: market cap DKK 37.36M, P/E 22.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is DKK 37.36M; P/E is 22.4.

Peer valuation comparison

Latest P/E is 22.42x versus a Healthcare sector median of 24.46x (8.3% below).

Latest P/E is 22.42x versus a Denmark median of 19.06x (17.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025DKK 309.00K-DKK 859.00K-DKK 2.14Mn/a-21DKK 394.00Kn/aDKK 18.39M
FY2024DKK 0-DKK 298.00K-DKK 3.36Mn/a-8DKK 3.89Mn/aDKK 19.25M
FY2023DKK 0-DKK 26.05M-DKK 20.02Mn/a-738DKK 11.27Mn/aDKK 14.24M
FY2021DKK 0-DKK 626.54M-DKK 603.57Mn/a-17940DKK 102.26MDKK 39.97MDKK 9.34M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-29DKK 37.36M22.4n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 DKK.

About STRAP

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is STRAP's market cap?

STRAP's market capitalization is DKK 37.36M.

What is STRAP's P/E ratio?

STRAP's price-to-earnings (P/E) ratio is 22.4.

What does STRAP do?

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.